Sociedad Americana de Hirudoterapia

Annexin A1: potential for glucocorticoid sparing in RA

Review published in Nature reviews. Rheumatology (2013)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewSeguridad y control de infeccionesYang YH et al. · Nature reviews. Rheumatology, 2013

Abstract

Glucocorticoids have broad-ranging and powerful anti-inflammatory and immunomodulatory effects. Unsurprisingly, therefore, glucocorticoids are widely and persistently used to treat a large number of inflammatory diseases, including rheumatoid arthritis (RA), despite the well-described adverse effects of these drugs. Annexin A1 is a glucocorticoid-induced molecule that is known to replicate many of the described anti-inflammatory effects of glucocorticoids. In addition to the well-documented roles of this protein in neutrophil function, emerging evidence suggests that annexin A1 is involved in the modulation of T-cell function and the adaptive immune responses relevant to RA. Interest in annexin A1 was renewed after the delineation of the receptors for this protein. This breakthrough also led to advances in our understanding of anti-inflammatory annexin A1 mimetic peptides and agonistic compounds targeting these receptors, particularly those specific for the receptor N-formyl peptide receptor 2 (FPR2). Herein, we review the current knowledge of the biological activities of annexin A1 and their relevance to RA pathogenesis. We also discuss the potential of annexin A1 mimics and strategies aimed at potentiating annexin A1 signalling to become viable approaches to minimizing glucocorticoid use in RA and other inflammatory disorders.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAdaptive ImmunityAnnexin A1Arthritis, RheumatoidGlucocorticoidsHumansReceptors, Formyl PeptideReceptors, LipoxinSignal TransductionT-Lymphocytes

Resumen

Glucocorticoids have broad-ranging and powerful anti-inflammatory and immunomodulatory effects.

Por qué esto importa para la hirudoterapia

This review examines the biological activities of Annexin A1, a glucocorticoid-induced anti-inflammatory protein that modulates T-cell function, exploring its potential to minimize glucocorticoid use in treating rheumatoid arthritis. The article discusses protein mechanisms, FPR2 receptors, and Annexin A1 mimetic peptides and agonistic compounds without making any reference to leeches or leech-derived molecules. The study does not evaluate hirudotherapy. Therefore, its relevance to the American Society of Hirudotherapy is entirely indirect, limited to the broader context of anti-inflammatory therapeutic strategies.

Citación

Annexin A1: potential for glucocorticoid sparing in RA

Yang YH et al. · Nature reviews. Rheumatology, 2013

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.